SlideShare une entreprise Scribd logo
1  sur  18
Télécharger pour lire hors ligne
Comprehensive
Drug Abuse Prevention
and Control Act
(Controlled Substance
Act, 1970)
       BY SAKSHI DAHIYA
       MPHARM(DRA) 1ST SEM
                             1
Key points:-
• “Federalization” or
 “nationalization” of drug control
• This act forms the basis of
     federal    government
 enforcement efforts.
 Defines a drug-dependent person.
 Established five categories of scheduled
  drugs (controlled substances).
 Provides for strict regulation of controlled
  substances
                                           2
1970 - Comprehensive Drug Abuse
 Prevention and Control Act - consolidates
 previous drug laws and reduces penalties
 for marijuana possession. It also
 strengthens law enforcement by allowing
 police to conduct "no-knock" searches
The Drug Enforcement Agency (DEA) was
 formed to enforce the laws concerning
 narcotics and their distribution
 Created a stair-step schedule of
 controlled substances
                                        3
What is a Drug?
A drug may be any
ingestive substance
that has a noticeable
effect upon the mind or
body.
                          4
This act divided substances with
abuse potential into categories
based on the degree of their abuse
potential and clinical usefulness
Schedules I, II, III, IV, V which
classify psychoactive drugs
according to degree of
psychoactivity and abuse potential

                               5
Schedule I substances have high-abuse
 potential and no currently approved
 medicinal uses; they cannot be prescribed.
Schedule II substances have high-abuse
 potential but are approved for medical
 uses and can be prescribed.
Schedule I–V reflects the likelihood of
 abuse and clinical usefulness




                                              6
Controlled Substance Act
Schedule I -         •   heroin
(MOST DANGEROUS) •       LSD
Controlled           •
substances that have
                         mescaline
no established       •   peyote
medical usage,       •   methaqualone
cannot be used
safely, and have
                     •   psilocybin
great potential for  •   marijuana
abuse. This schedule •   hashish
includes:
                     •   other specified
                            hallucinogens
                                            7
Controlled Substance Act
Schedule II -
Substances defined as
drugs with high abuse
potential for which there   •   opium
is currently accepted       •   morphine
pharmacological or          •   codeine
medical use. Most are       •   cocaine
considered addictive.       •   PCP
Examples:                   •   other
                                  derivatives
                                                8
Controlled Substance Act
Schedule III -

This schedule involves
lower abuse potential
than drugs in Schedules
I or II. They have an      • Many drugs
accepted medical use,         found in
but may lead to high
level of psychological        Schedule II,
dependence or to              but in
moderate or low physical      derivative or
dependence. Examples          diluted form.
include:
                                              9
Controlled Substance Act
Schedule IV -
These have a relatively
low potential for abuse,
are useful in
established medical        • depressants
treatments, and involve    • minor
only limited risk of          tranquilizers
psychological or           • some
physical dependency.          stimulants
Examples include:
                                          10
Controlled Substance Act
Schedule V -
(Least Dangerous)
Prescription drugs    • Cough medicines
with low potential       containing opium,
for abuse and only       morphine, or
limited possibility      codeine
for psychological     • Anti-diarrhetics
or physical              containing opium,
dependence.              morphine, or
Examples:                codeine.
                                       11
 It is a United States federal law  requires
the pharmaceutical industry to maintain
physical security and strict record keeping
for certain types of drugs. 
 The CSA is the federal U.S. drug policy
 under which the manufacture, importation,
possession, use and distribution of certain
substances is regulated.
This law is a consolidation of numerous laws
regulating the manufacture and distribution
of narcotics, stimulants, depressants, 
hallucinogens, anabolic steroids, and
chemicals used in the illicit production of
controlled substances. The act also provides
a mechanism for substances to be controlled,
added to a schedule, decontrolled, removed
from control, rescheduled, or transferred
from one schedule to another.               12
Proceedings to add, delete, or change
 the schedule of a drug or other
 substance may be initiated by the 
 Drug Enforcement Administration
  (DEA), the
 Department of Health and Human Service
  (HHS)
The DEA also may begin an investigation
 of a drug at any time based upon
 information received from law enforce
 -ment laboratories, state,local law
 enforcement andregulatory agencies, or
                                   13
DEA(data)                  HHS
Administrator              request


   drug to           Assistant
 be controlled    secretaryHealth HHS
or not

          commissioner     Evaluation from
              FDA              NIDA

                                         14
Once the DEA has collected the
necessary data, the Administrator of the
Drug Enforcement Association, by
authority of the Attorney General,
requests from the HHS a scientific and
medical evaluation and recommendation as
to whether the drug or other substance
should be controlled or removed from
control. This request is sent to the
Assistant Secretary of Health of the
HHS,  Then, the HHS solicits information
from the Commissioner of the Food and
Drug Administration and
                                     15
and evaluations and recommendations
 from the National Institute on Drug
 Abuse,  and on occasion, from the
 scientific and medical community.
 The Assistant Secretary, by authority
 of the Secretary, compiles the
 information and transmits back to the
 DEA a medical and scientific evaluation
 regarding the drug or other substance,
 a recommendation as to whether the
 drug should be controlled, and in what
 schedule it should be placed.
                                       16
Every schedule otherwise requires finding and
 specifying the "potential for abuse" before a
 substance can be placed in that schedule.[16]The
 specific classification of any given drug or other
 substance is usually a source of controversy, as is
 the purpose and effectiveness of the entire
 regulatory scheme.
"The term 'controlled substance' means a drug or
 other substance, or immediate precursor, included
 in schedule I, II, III, IV, or V . The term does not
 include distilled spirits, wine, malt beverages, or
 tobacco, as those terms are defined or used in
 subtitle E of the Internal Revenue Code of
 1986." 21 U.S.C. § 802(6)

                                                  17
18

Contenu connexe

Tendances

Narcotic and Psychotropic Substance act 1985
Narcotic and Psychotropic Substance act 1985Narcotic and Psychotropic Substance act 1985
Narcotic and Psychotropic Substance act 1985Prakash Mali
 
Drugs and Cosmatic Act,1940 and its rules 1945
Drugs and Cosmatic Act,1940 and its rules 1945Drugs and Cosmatic Act,1940 and its rules 1945
Drugs and Cosmatic Act,1940 and its rules 1945TameshSonkar
 
Drug Price Control Order -2013
Drug Price Control Order -2013Drug Price Control Order -2013
Drug Price Control Order -2013Ganesh Shevalkar
 
DPCO-Drug price control order
DPCO-Drug price control orderDPCO-Drug price control order
DPCO-Drug price control orderANANT NAG
 
Drugs and Magic Remedies (Objectionable Advertisements), 1954 Act,1954
Drugs and Magic Remedies (Objectionable Advertisements), 1954 Act,1954 Drugs and Magic Remedies (Objectionable Advertisements), 1954 Act,1954
Drugs and Magic Remedies (Objectionable Advertisements), 1954 Act,1954 Sagar Savale
 
Retail marketing in retail pharmacy
Retail marketing in retail pharmacyRetail marketing in retail pharmacy
Retail marketing in retail pharmacyRukesh Machamasi
 
Pharmacy Act ,1948
Pharmacy Act ,1948Pharmacy Act ,1948
Pharmacy Act ,1948Gaurav Patil
 
Drugs & Cosmetics Act 1940 & its Rules 1945 Part-I
Drugs & Cosmetics Act 1940 & its Rules 1945 Part-IDrugs & Cosmetics Act 1940 & its Rules 1945 Part-I
Drugs & Cosmetics Act 1940 & its Rules 1945 Part-IPranay Sethiya
 
Goverment analyst and Drug inspector
Goverment analyst and Drug inspectorGoverment analyst and Drug inspector
Goverment analyst and Drug inspectorDr. Supriya Suman
 
drugs and cosmetics act Unit 1 part 1
 drugs and cosmetics act Unit 1 part 1 drugs and cosmetics act Unit 1 part 1
drugs and cosmetics act Unit 1 part 1shashankc10
 
Drugs and magic remedies act
Drugs and magic remedies actDrugs and magic remedies act
Drugs and magic remedies actAmit Satpute
 
Codes of pharmaceutical ethics
Codes of pharmaceutical ethicsCodes of pharmaceutical ethics
Codes of pharmaceutical ethicsAshish Chaudhari
 
National pharmaceutical pricing authority
National pharmaceutical pricing authority National pharmaceutical pricing authority
National pharmaceutical pricing authority TiyaPatel2
 

Tendances (20)

Narcotic and Psychotropic Substance act 1985
Narcotic and Psychotropic Substance act 1985Narcotic and Psychotropic Substance act 1985
Narcotic and Psychotropic Substance act 1985
 
Drug addiction and drug abuse
Drug addiction and drug abuseDrug addiction and drug abuse
Drug addiction and drug abuse
 
Drugs and Cosmatic Act,1940 and its rules 1945
Drugs and Cosmatic Act,1940 and its rules 1945Drugs and Cosmatic Act,1940 and its rules 1945
Drugs and Cosmatic Act,1940 and its rules 1945
 
Drug Price Control Order -2013
Drug Price Control Order -2013Drug Price Control Order -2013
Drug Price Control Order -2013
 
Unit 5 National Drug Policy.pdf
Unit 5 National Drug Policy.pdfUnit 5 National Drug Policy.pdf
Unit 5 National Drug Policy.pdf
 
DPCO-Drug price control order
DPCO-Drug price control orderDPCO-Drug price control order
DPCO-Drug price control order
 
Drugs and Magic Remedies (Objectionable Advertisements), 1954 Act,1954
Drugs and Magic Remedies (Objectionable Advertisements), 1954 Act,1954 Drugs and Magic Remedies (Objectionable Advertisements), 1954 Act,1954
Drugs and Magic Remedies (Objectionable Advertisements), 1954 Act,1954
 
Pharmaceutical ethics
Pharmaceutical ethicsPharmaceutical ethics
Pharmaceutical ethics
 
Retail marketing in retail pharmacy
Retail marketing in retail pharmacyRetail marketing in retail pharmacy
Retail marketing in retail pharmacy
 
Pharmacy Act ,1948
Pharmacy Act ,1948Pharmacy Act ,1948
Pharmacy Act ,1948
 
Drugs & Cosmetics Act 1940 & its Rules 1945 Part-I
Drugs & Cosmetics Act 1940 & its Rules 1945 Part-IDrugs & Cosmetics Act 1940 & its Rules 1945 Part-I
Drugs & Cosmetics Act 1940 & its Rules 1945 Part-I
 
Drug & Magic Remedies Act 1954 Part-1
Drug & Magic Remedies Act 1954 Part-1 Drug & Magic Remedies Act 1954 Part-1
Drug & Magic Remedies Act 1954 Part-1
 
Goverment analyst and Drug inspector
Goverment analyst and Drug inspectorGoverment analyst and Drug inspector
Goverment analyst and Drug inspector
 
Drug addiction and drug abuse ppt
Drug addiction and drug abuse  pptDrug addiction and drug abuse  ppt
Drug addiction and drug abuse ppt
 
INTRODUCTION OF CLINICAL PHARMACY
INTRODUCTION OF CLINICAL PHARMACYINTRODUCTION OF CLINICAL PHARMACY
INTRODUCTION OF CLINICAL PHARMACY
 
drugs and cosmetics act Unit 1 part 1
 drugs and cosmetics act Unit 1 part 1 drugs and cosmetics act Unit 1 part 1
drugs and cosmetics act Unit 1 part 1
 
Drugs and magic remedies act
Drugs and magic remedies actDrugs and magic remedies act
Drugs and magic remedies act
 
Drugs and cosmetics act 1940
Drugs and cosmetics act 1940Drugs and cosmetics act 1940
Drugs and cosmetics act 1940
 
Codes of pharmaceutical ethics
Codes of pharmaceutical ethicsCodes of pharmaceutical ethics
Codes of pharmaceutical ethics
 
National pharmaceutical pricing authority
National pharmaceutical pricing authority National pharmaceutical pricing authority
National pharmaceutical pricing authority
 

En vedette

Drug abuse ppt
Drug abuse pptDrug abuse ppt
Drug abuse pptDFC2011
 
Addressing drug use and changing legal and social
Addressing drug use and changing legal and socialAddressing drug use and changing legal and social
Addressing drug use and changing legal and socialGreg Chartier, PhD
 
Drugs PPT - sociology - shubham parsekar
Drugs PPT - sociology - shubham parsekarDrugs PPT - sociology - shubham parsekar
Drugs PPT - sociology - shubham parsekarShubham Parsekar
 
Drug development and regulation
Drug development and regulationDrug development and regulation
Drug development and regulationraj kumar
 
Birth & death information automation
Birth & death information automationBirth & death information automation
Birth & death information automationSaeed Siddik
 
The clinical establishments (registration and regulation) act 2010 and rules...
The clinical establishments (registration and  regulation) act 2010 and rules...The clinical establishments (registration and  regulation) act 2010 and rules...
The clinical establishments (registration and regulation) act 2010 and rules...Dr. Priyanka Srivastava
 
The Clinical Establishments (Registration & Regulation) Act mithun kherde
The Clinical Establishments (Registration & Regulation) Act mithun kherdeThe Clinical Establishments (Registration & Regulation) Act mithun kherde
The Clinical Establishments (Registration & Regulation) Act mithun kherdemithun.kherde
 
Clinical establishment act
Clinical establishment actClinical establishment act
Clinical establishment actShambhu N
 
Gas cylinder rule_2004
Gas cylinder rule_2004Gas cylinder rule_2004
Gas cylinder rule_2004GirishBarve
 
Drug Abuse PPT by nirav
Drug Abuse PPT by niravDrug Abuse PPT by nirav
Drug Abuse PPT by niravniravkd
 
"DRUG ABUSE" BETTER LATE THAN NEVER
"DRUG ABUSE" BETTER LATE THAN NEVER"DRUG ABUSE" BETTER LATE THAN NEVER
"DRUG ABUSE" BETTER LATE THAN NEVERsyakilahnorazmi
 
Drug Abuse and its Prevention
Drug Abuse and its PreventionDrug Abuse and its Prevention
Drug Abuse and its PreventionFrenz Delgado
 
Registration of births & deaths act ppt
Registration of births & deaths act pptRegistration of births & deaths act ppt
Registration of births & deaths act ppt Dr.Priyanka Phonde
 
Alcohol drug awareness
Alcohol drug awarenessAlcohol drug awareness
Alcohol drug awarenessRCIPS
 
Central excise act
Central excise actCentral excise act
Central excise actVinod K Raju
 

En vedette (20)

Drug abuse ppt
Drug abuse pptDrug abuse ppt
Drug abuse ppt
 
Addressing drug use and changing legal and social
Addressing drug use and changing legal and socialAddressing drug use and changing legal and social
Addressing drug use and changing legal and social
 
Drugs & substance abuse at workplace
Drugs & substance abuse at workplaceDrugs & substance abuse at workplace
Drugs & substance abuse at workplace
 
Drugs PPT - sociology - shubham parsekar
Drugs PPT - sociology - shubham parsekarDrugs PPT - sociology - shubham parsekar
Drugs PPT - sociology - shubham parsekar
 
Drug development and regulation
Drug development and regulationDrug development and regulation
Drug development and regulation
 
Atomic energy
Atomic energyAtomic energy
Atomic energy
 
Birth & death information automation
Birth & death information automationBirth & death information automation
Birth & death information automation
 
Cotpa 03
Cotpa 03Cotpa 03
Cotpa 03
 
The clinical establishments (registration and regulation) act 2010 and rules...
The clinical establishments (registration and  regulation) act 2010 and rules...The clinical establishments (registration and  regulation) act 2010 and rules...
The clinical establishments (registration and regulation) act 2010 and rules...
 
The Clinical Establishments (Registration & Regulation) Act mithun kherde
The Clinical Establishments (Registration & Regulation) Act mithun kherdeThe Clinical Establishments (Registration & Regulation) Act mithun kherde
The Clinical Establishments (Registration & Regulation) Act mithun kherde
 
Clinical establishment act
Clinical establishment actClinical establishment act
Clinical establishment act
 
Gas cylinder rule_2004
Gas cylinder rule_2004Gas cylinder rule_2004
Gas cylinder rule_2004
 
Drug Abuse PPT by nirav
Drug Abuse PPT by niravDrug Abuse PPT by nirav
Drug Abuse PPT by nirav
 
"DRUG ABUSE" BETTER LATE THAN NEVER
"DRUG ABUSE" BETTER LATE THAN NEVER"DRUG ABUSE" BETTER LATE THAN NEVER
"DRUG ABUSE" BETTER LATE THAN NEVER
 
Drug abuse prathyusha
Drug abuse prathyushaDrug abuse prathyusha
Drug abuse prathyusha
 
Drug Abuse and its Prevention
Drug Abuse and its PreventionDrug Abuse and its Prevention
Drug Abuse and its Prevention
 
The pharmacy act
The pharmacy actThe pharmacy act
The pharmacy act
 
Registration of births & deaths act ppt
Registration of births & deaths act pptRegistration of births & deaths act ppt
Registration of births & deaths act ppt
 
Alcohol drug awareness
Alcohol drug awarenessAlcohol drug awareness
Alcohol drug awareness
 
Central excise act
Central excise actCentral excise act
Central excise act
 

Similaire à Drug abuse & control act 1970 ppt dra2

Chapter 3 Drugs & Society
Chapter 3 Drugs & SocietyChapter 3 Drugs & Society
Chapter 3 Drugs & SocietyMichelle Meyer
 
Drugs & Society Chapter 3
Drugs & Society Chapter 3Drugs & Society Chapter 3
Drugs & Society Chapter 3Michelle Meyer
 
Hanson 10e Pp Ts Ch03
Hanson 10e Pp Ts Ch03Hanson 10e Pp Ts Ch03
Hanson 10e Pp Ts Ch03Bryan
 
Acts related to addiction psychiatry
Acts related to addiction psychiatryActs related to addiction psychiatry
Acts related to addiction psychiatryDr. Sunil Suthar
 
Controlled drugs
Controlled drugsControlled drugs
Controlled drugsDarya Daoud
 
MRA201 T. Unit 1 Regulatory aspects of drugs and cosmetics unit 1.pptx
MRA201 T. Unit 1 Regulatory aspects of drugs and cosmetics unit 1.pptxMRA201 T. Unit 1 Regulatory aspects of drugs and cosmetics unit 1.pptx
MRA201 T. Unit 1 Regulatory aspects of drugs and cosmetics unit 1.pptxDimple Marathe
 
Investaigational drugs
Investaigational drugsInvestaigational drugs
Investaigational drugsSultan Alharbi
 
Pain meds powerpoint.1
Pain meds powerpoint.1Pain meds powerpoint.1
Pain meds powerpoint.1ageril
 
OTC drugs (Amended rules) Drug and Cosmetic Act, 1940 & Rules,1945
OTC drugs (Amended rules) Drug and Cosmetic Act, 1940 & Rules,1945OTC drugs (Amended rules) Drug and Cosmetic Act, 1940 & Rules,1945
OTC drugs (Amended rules) Drug and Cosmetic Act, 1940 & Rules,1945Yamini Shah
 
MHRA and USFDA simultaneously data
MHRA and USFDA simultaneously dataMHRA and USFDA simultaneously data
MHRA and USFDA simultaneously data66VaibhavWaghchaure
 
Nstp prefinals documentation lyn2 copy
Nstp prefinals documentation lyn2   copyNstp prefinals documentation lyn2   copy
Nstp prefinals documentation lyn2 copyMary Lyn Enguerra
 
Overview regulatory environment in usa,europe,india
Overview regulatory environment in usa,europe,indiaOverview regulatory environment in usa,europe,india
Overview regulatory environment in usa,europe,indiashabana parveen
 
Regulatory Requirements For New Drug Approval
Regulatory Requirements For New Drug ApprovalRegulatory Requirements For New Drug Approval
Regulatory Requirements For New Drug ApprovalShagufta Farooqui
 

Similaire à Drug abuse & control act 1970 ppt dra2 (20)

Drug Schedules
Drug SchedulesDrug Schedules
Drug Schedules
 
Drug_Scheduling.pptx
Drug_Scheduling.pptxDrug_Scheduling.pptx
Drug_Scheduling.pptx
 
Chapter 3 Drugs & Society
Chapter 3 Drugs & SocietyChapter 3 Drugs & Society
Chapter 3 Drugs & Society
 
Drugs & Society Chapter 3
Drugs & Society Chapter 3Drugs & Society Chapter 3
Drugs & Society Chapter 3
 
Ethics chapter
Ethics chapterEthics chapter
Ethics chapter
 
Hanson 10e Pp Ts Ch03
Hanson 10e Pp Ts Ch03Hanson 10e Pp Ts Ch03
Hanson 10e Pp Ts Ch03
 
Drug schedules
Drug schedulesDrug schedules
Drug schedules
 
Drug scheduling in india
Drug scheduling in indiaDrug scheduling in india
Drug scheduling in india
 
Acts related to addiction psychiatry
Acts related to addiction psychiatryActs related to addiction psychiatry
Acts related to addiction psychiatry
 
Controlled drugs
Controlled drugsControlled drugs
Controlled drugs
 
MRA201 T. Unit 1 Regulatory aspects of drugs and cosmetics unit 1.pptx
MRA201 T. Unit 1 Regulatory aspects of drugs and cosmetics unit 1.pptxMRA201 T. Unit 1 Regulatory aspects of drugs and cosmetics unit 1.pptx
MRA201 T. Unit 1 Regulatory aspects of drugs and cosmetics unit 1.pptx
 
Investaigational drugs
Investaigational drugsInvestaigational drugs
Investaigational drugs
 
Pain meds powerpoint.1
Pain meds powerpoint.1Pain meds powerpoint.1
Pain meds powerpoint.1
 
OTC drugs (Amended rules) Drug and Cosmetic Act, 1940 & Rules,1945
OTC drugs (Amended rules) Drug and Cosmetic Act, 1940 & Rules,1945OTC drugs (Amended rules) Drug and Cosmetic Act, 1940 & Rules,1945
OTC drugs (Amended rules) Drug and Cosmetic Act, 1940 & Rules,1945
 
MHRA and USFDA simultaneously data
MHRA and USFDA simultaneously dataMHRA and USFDA simultaneously data
MHRA and USFDA simultaneously data
 
Basic Introduction of drugs 1.pptx
Basic Introduction of drugs 1.pptxBasic Introduction of drugs 1.pptx
Basic Introduction of drugs 1.pptx
 
Nstp prefinals documentation lyn2 copy
Nstp prefinals documentation lyn2   copyNstp prefinals documentation lyn2   copy
Nstp prefinals documentation lyn2 copy
 
Pharma 1
Pharma 1Pharma 1
Pharma 1
 
Overview regulatory environment in usa,europe,india
Overview regulatory environment in usa,europe,indiaOverview regulatory environment in usa,europe,india
Overview regulatory environment in usa,europe,india
 
Regulatory Requirements For New Drug Approval
Regulatory Requirements For New Drug ApprovalRegulatory Requirements For New Drug Approval
Regulatory Requirements For New Drug Approval
 

Plus de bdvfgbdhg

Scale up and post approval changes(supac)
Scale up and post approval changes(supac)Scale up and post approval changes(supac)
Scale up and post approval changes(supac)bdvfgbdhg
 
Priscription drug user free act......sn
Priscription drug user free act......snPriscription drug user free act......sn
Priscription drug user free act......snbdvfgbdhg
 
Medical device
Medical deviceMedical device
Medical devicebdvfgbdhg
 
Labeling in india
Labeling in indiaLabeling in india
Labeling in indiabdvfgbdhg
 
Registration procedure of drugs in european union
Registration procedure of drugs in european unionRegistration procedure of drugs in european union
Registration procedure of drugs in european unionbdvfgbdhg
 
National pharmaceutical pricing athourity (nppa)
National pharmaceutical pricing athourity (nppa)National pharmaceutical pricing athourity (nppa)
National pharmaceutical pricing athourity (nppa)bdvfgbdhg
 
Central drug standard control organisation
Central drug standard control organisationCentral drug standard control organisation
Central drug standard control organisationbdvfgbdhg
 
Bulk active post approval changes
Bulk active post approval changesBulk active post approval changes
Bulk active post approval changesbdvfgbdhg
 
Post marketing servillence
Post marketing servillencePost marketing servillence
Post marketing servillencebdvfgbdhg
 
Post marketing servillence
Post marketing servillencePost marketing servillence
Post marketing servillencebdvfgbdhg
 

Plus de bdvfgbdhg (12)

Snda
SndaSnda
Snda
 
Scale up and post approval changes(supac)
Scale up and post approval changes(supac)Scale up and post approval changes(supac)
Scale up and post approval changes(supac)
 
Priscription drug user free act......sn
Priscription drug user free act......snPriscription drug user free act......sn
Priscription drug user free act......sn
 
Nppa
NppaNppa
Nppa
 
Medical device
Medical deviceMedical device
Medical device
 
Labeling in india
Labeling in indiaLabeling in india
Labeling in india
 
Registration procedure of drugs in european union
Registration procedure of drugs in european unionRegistration procedure of drugs in european union
Registration procedure of drugs in european union
 
National pharmaceutical pricing athourity (nppa)
National pharmaceutical pricing athourity (nppa)National pharmaceutical pricing athourity (nppa)
National pharmaceutical pricing athourity (nppa)
 
Central drug standard control organisation
Central drug standard control organisationCentral drug standard control organisation
Central drug standard control organisation
 
Bulk active post approval changes
Bulk active post approval changesBulk active post approval changes
Bulk active post approval changes
 
Post marketing servillence
Post marketing servillencePost marketing servillence
Post marketing servillence
 
Post marketing servillence
Post marketing servillencePost marketing servillence
Post marketing servillence
 

Dernier

Over the counter (OTC)- Sale, rational use.pptx
Over the counter (OTC)- Sale, rational use.pptxOver the counter (OTC)- Sale, rational use.pptx
Over the counter (OTC)- Sale, rational use.pptxraviapr7
 
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptxSandy Millin
 
How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17Celine George
 
How to Add Existing Field in One2Many Tree View in Odoo 17
How to Add Existing Field in One2Many Tree View in Odoo 17How to Add Existing Field in One2Many Tree View in Odoo 17
How to Add Existing Field in One2Many Tree View in Odoo 17Celine George
 
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdfP4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdfYu Kanazawa / Osaka University
 
KARNAADA.pptx made by - saransh dwivedi ( SD ) - SHALAKYA TANTRA - ENT - 4...
KARNAADA.pptx  made by -  saransh dwivedi ( SD ) -  SHALAKYA TANTRA - ENT - 4...KARNAADA.pptx  made by -  saransh dwivedi ( SD ) -  SHALAKYA TANTRA - ENT - 4...
KARNAADA.pptx made by - saransh dwivedi ( SD ) - SHALAKYA TANTRA - ENT - 4...M56BOOKSTORE PRODUCT/SERVICE
 
How to Manage Cross-Selling in Odoo 17 Sales
How to Manage Cross-Selling in Odoo 17 SalesHow to Manage Cross-Selling in Odoo 17 Sales
How to Manage Cross-Selling in Odoo 17 SalesCeline George
 
How to Send Emails From Odoo 17 Using Code
How to Send Emails From Odoo 17 Using CodeHow to Send Emails From Odoo 17 Using Code
How to Send Emails From Odoo 17 Using CodeCeline George
 
Quality Assurance_GOOD LABORATORY PRACTICE
Quality Assurance_GOOD LABORATORY PRACTICEQuality Assurance_GOOD LABORATORY PRACTICE
Quality Assurance_GOOD LABORATORY PRACTICESayali Powar
 
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRADUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRATanmoy Mishra
 
The basics of sentences session 10pptx.pptx
The basics of sentences session 10pptx.pptxThe basics of sentences session 10pptx.pptx
The basics of sentences session 10pptx.pptxheathfieldcps1
 
AUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptxAUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptxiammrhaywood
 
Unveiling the Intricacies of Leishmania donovani: Structure, Life Cycle, Path...
Unveiling the Intricacies of Leishmania donovani: Structure, Life Cycle, Path...Unveiling the Intricacies of Leishmania donovani: Structure, Life Cycle, Path...
Unveiling the Intricacies of Leishmania donovani: Structure, Life Cycle, Path...Dr. Asif Anas
 
Slides CapTechTalks Webinar March 2024 Joshua Sinai.pptx
Slides CapTechTalks Webinar March 2024 Joshua Sinai.pptxSlides CapTechTalks Webinar March 2024 Joshua Sinai.pptx
Slides CapTechTalks Webinar March 2024 Joshua Sinai.pptxCapitolTechU
 
EBUS5423 Data Analytics and Reporting Bl
EBUS5423 Data Analytics and Reporting BlEBUS5423 Data Analytics and Reporting Bl
EBUS5423 Data Analytics and Reporting BlDr. Bruce A. Johnson
 
Prescribed medication order and communication skills.pptx
Prescribed medication order and communication skills.pptxPrescribed medication order and communication skills.pptx
Prescribed medication order and communication skills.pptxraviapr7
 
3.21.24 The Origins of Black Power.pptx
3.21.24  The Origins of Black Power.pptx3.21.24  The Origins of Black Power.pptx
3.21.24 The Origins of Black Power.pptxmary850239
 
CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...
CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...
CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...Nguyen Thanh Tu Collection
 

Dernier (20)

Over the counter (OTC)- Sale, rational use.pptx
Over the counter (OTC)- Sale, rational use.pptxOver the counter (OTC)- Sale, rational use.pptx
Over the counter (OTC)- Sale, rational use.pptx
 
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
 
How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17
 
How to Add Existing Field in One2Many Tree View in Odoo 17
How to Add Existing Field in One2Many Tree View in Odoo 17How to Add Existing Field in One2Many Tree View in Odoo 17
How to Add Existing Field in One2Many Tree View in Odoo 17
 
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdfP4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
 
KARNAADA.pptx made by - saransh dwivedi ( SD ) - SHALAKYA TANTRA - ENT - 4...
KARNAADA.pptx  made by -  saransh dwivedi ( SD ) -  SHALAKYA TANTRA - ENT - 4...KARNAADA.pptx  made by -  saransh dwivedi ( SD ) -  SHALAKYA TANTRA - ENT - 4...
KARNAADA.pptx made by - saransh dwivedi ( SD ) - SHALAKYA TANTRA - ENT - 4...
 
How to Manage Cross-Selling in Odoo 17 Sales
How to Manage Cross-Selling in Odoo 17 SalesHow to Manage Cross-Selling in Odoo 17 Sales
How to Manage Cross-Selling in Odoo 17 Sales
 
How to Send Emails From Odoo 17 Using Code
How to Send Emails From Odoo 17 Using CodeHow to Send Emails From Odoo 17 Using Code
How to Send Emails From Odoo 17 Using Code
 
Quality Assurance_GOOD LABORATORY PRACTICE
Quality Assurance_GOOD LABORATORY PRACTICEQuality Assurance_GOOD LABORATORY PRACTICE
Quality Assurance_GOOD LABORATORY PRACTICE
 
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRADUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
 
The basics of sentences session 10pptx.pptx
The basics of sentences session 10pptx.pptxThe basics of sentences session 10pptx.pptx
The basics of sentences session 10pptx.pptx
 
Personal Resilience in Project Management 2 - TV Edit 1a.pdf
Personal Resilience in Project Management 2 - TV Edit 1a.pdfPersonal Resilience in Project Management 2 - TV Edit 1a.pdf
Personal Resilience in Project Management 2 - TV Edit 1a.pdf
 
AUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptxAUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptx
 
Unveiling the Intricacies of Leishmania donovani: Structure, Life Cycle, Path...
Unveiling the Intricacies of Leishmania donovani: Structure, Life Cycle, Path...Unveiling the Intricacies of Leishmania donovani: Structure, Life Cycle, Path...
Unveiling the Intricacies of Leishmania donovani: Structure, Life Cycle, Path...
 
Slides CapTechTalks Webinar March 2024 Joshua Sinai.pptx
Slides CapTechTalks Webinar March 2024 Joshua Sinai.pptxSlides CapTechTalks Webinar March 2024 Joshua Sinai.pptx
Slides CapTechTalks Webinar March 2024 Joshua Sinai.pptx
 
EBUS5423 Data Analytics and Reporting Bl
EBUS5423 Data Analytics and Reporting BlEBUS5423 Data Analytics and Reporting Bl
EBUS5423 Data Analytics and Reporting Bl
 
Prescribed medication order and communication skills.pptx
Prescribed medication order and communication skills.pptxPrescribed medication order and communication skills.pptx
Prescribed medication order and communication skills.pptx
 
3.21.24 The Origins of Black Power.pptx
3.21.24  The Origins of Black Power.pptx3.21.24  The Origins of Black Power.pptx
3.21.24 The Origins of Black Power.pptx
 
Prelims of Kant get Marx 2.0: a general politics quiz
Prelims of Kant get Marx 2.0: a general politics quizPrelims of Kant get Marx 2.0: a general politics quiz
Prelims of Kant get Marx 2.0: a general politics quiz
 
CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...
CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...
CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...
 

Drug abuse & control act 1970 ppt dra2

  • 1. Comprehensive Drug Abuse Prevention and Control Act (Controlled Substance Act, 1970) BY SAKSHI DAHIYA MPHARM(DRA) 1ST SEM 1
  • 2. Key points:- • “Federalization” or “nationalization” of drug control • This act forms the basis of federal government enforcement efforts. Defines a drug-dependent person. Established five categories of scheduled drugs (controlled substances). Provides for strict regulation of controlled substances 2
  • 3. 1970 - Comprehensive Drug Abuse Prevention and Control Act - consolidates previous drug laws and reduces penalties for marijuana possession. It also strengthens law enforcement by allowing police to conduct "no-knock" searches The Drug Enforcement Agency (DEA) was formed to enforce the laws concerning narcotics and their distribution  Created a stair-step schedule of controlled substances 3
  • 4. What is a Drug? A drug may be any ingestive substance that has a noticeable effect upon the mind or body. 4
  • 5. This act divided substances with abuse potential into categories based on the degree of their abuse potential and clinical usefulness Schedules I, II, III, IV, V which classify psychoactive drugs according to degree of psychoactivity and abuse potential 5
  • 6. Schedule I substances have high-abuse potential and no currently approved medicinal uses; they cannot be prescribed. Schedule II substances have high-abuse potential but are approved for medical uses and can be prescribed. Schedule I–V reflects the likelihood of abuse and clinical usefulness 6
  • 7. Controlled Substance Act Schedule I - • heroin (MOST DANGEROUS) • LSD Controlled • substances that have mescaline no established • peyote medical usage, • methaqualone cannot be used safely, and have • psilocybin great potential for • marijuana abuse. This schedule • hashish includes: • other specified hallucinogens 7
  • 8. Controlled Substance Act Schedule II - Substances defined as drugs with high abuse potential for which there • opium is currently accepted • morphine pharmacological or • codeine medical use. Most are • cocaine considered addictive. • PCP Examples: • other derivatives 8
  • 9. Controlled Substance Act Schedule III - This schedule involves lower abuse potential than drugs in Schedules I or II. They have an • Many drugs accepted medical use, found in but may lead to high level of psychological Schedule II, dependence or to but in moderate or low physical derivative or dependence. Examples diluted form. include: 9
  • 10. Controlled Substance Act Schedule IV - These have a relatively low potential for abuse, are useful in established medical • depressants treatments, and involve • minor only limited risk of tranquilizers psychological or • some physical dependency. stimulants Examples include: 10
  • 11. Controlled Substance Act Schedule V - (Least Dangerous) Prescription drugs • Cough medicines with low potential containing opium, for abuse and only morphine, or limited possibility codeine for psychological • Anti-diarrhetics or physical containing opium, dependence. morphine, or Examples: codeine. 11
  • 12.  It is a United States federal law  requires the pharmaceutical industry to maintain physical security and strict record keeping for certain types of drugs.   The CSA is the federal U.S. drug policy  under which the manufacture, importation, possession, use and distribution of certain substances is regulated. This law is a consolidation of numerous laws regulating the manufacture and distribution of narcotics, stimulants, depressants,  hallucinogens, anabolic steroids, and chemicals used in the illicit production of controlled substances. The act also provides a mechanism for substances to be controlled, added to a schedule, decontrolled, removed from control, rescheduled, or transferred from one schedule to another. 12
  • 13. Proceedings to add, delete, or change the schedule of a drug or other substance may be initiated by the  Drug Enforcement Administration  (DEA), the Department of Health and Human Service  (HHS) The DEA also may begin an investigation of a drug at any time based upon information received from law enforce -ment laboratories, state,local law enforcement andregulatory agencies, or 13
  • 14. DEA(data) HHS Administrator request    drug to Assistant  be controlled secretaryHealth HHS or not   commissioner Evaluation from  FDA NIDA 14
  • 15. Once the DEA has collected the necessary data, the Administrator of the Drug Enforcement Association, by authority of the Attorney General, requests from the HHS a scientific and medical evaluation and recommendation as to whether the drug or other substance should be controlled or removed from control. This request is sent to the Assistant Secretary of Health of the HHS,  Then, the HHS solicits information from the Commissioner of the Food and Drug Administration and 15
  • 16. and evaluations and recommendations from the National Institute on Drug Abuse,  and on occasion, from the scientific and medical community. The Assistant Secretary, by authority of the Secretary, compiles the information and transmits back to the DEA a medical and scientific evaluation regarding the drug or other substance, a recommendation as to whether the drug should be controlled, and in what schedule it should be placed. 16
  • 17. Every schedule otherwise requires finding and specifying the "potential for abuse" before a substance can be placed in that schedule.[16]The specific classification of any given drug or other substance is usually a source of controversy, as is the purpose and effectiveness of the entire regulatory scheme. "The term 'controlled substance' means a drug or other substance, or immediate precursor, included in schedule I, II, III, IV, or V . The term does not include distilled spirits, wine, malt beverages, or tobacco, as those terms are defined or used in subtitle E of the Internal Revenue Code of 1986." 21 U.S.C. § 802(6) 17
  • 18. 18